Brief: vTv Therapeutics Says On July 17, Co Received Nasdaq Notice Approving Request To Extend Period To Regain Compliance With Min Bid Requirement Until Dec 18
20/07/2023 22:49
July 20 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS-ON JULY 17, RECEIVED NASDAQ NOTICE
APPROVING
REQUEST TO EXTEND CO'S PERIOD TO REGAIN COMPLIANCE WITH MIN BID
REQUIREMENT UNTIL DEC 18
Further company coverage: VTVT.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)